Patents by Inventor Elizabeth A Flynn
Elizabeth A Flynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10820976Abstract: A padded table for animal massage or body work having a flat square working surface with diagonally situated bumper pads supported on 4 sets of attached folding legs. Table construction includes two adjacent parallel sections joined in the middle with a piano-type hinge so that it may be closed and moved or carried easily as like a suitcase or unfolded to form a flat working surface. The double leg support structure on both sides of the adjacent parallel sections distributes the weight of animals who may move continually across the sections providing unique stability.Type: GrantFiled: June 13, 2018Date of Patent: November 3, 2020Inventor: Elizabeth A Flynn
-
Publication number: 20190053885Abstract: A padded table for animal massage or body work having a flat square working surface with diagonally situated bumper pads supported on 4 sets of attached folding legs. Table construction includes two adjacent parallel sections joined in the middle with a piano-type hinge so that it may be closed and moved or carried easily as like a suitcase or unfolded to form a flat working surface. The double leg support structure on both sides of the adjacent parallel sections distributes the weight of animals who may move continually across the sections providing unique stability.Type: ApplicationFiled: June 13, 2018Publication date: February 21, 2019Inventor: Elizabeth A Flynn
-
Patent number: 9409942Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies thereby facilitating rapid isolation and purification of recombinant proteins. The invention further provides methods for producing protein molecular weight ladders for us in protein gel electrophoresis, as well as proteins and protein molecular weight ladders produced by these methods.Type: GrantFiled: July 25, 2013Date of Patent: August 9, 2016Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20140097086Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies thereby facilitating rapid isolation and purification of recombinant proteins. The invention further provides methods for producing protein molecular weight ladders for us in protein gel electrophoresis, as well as proteins and protein molecular weight ladders produced by these methods.Type: ApplicationFiled: July 25, 2013Publication date: April 10, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Deb K. CHATTERJEE, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Patent number: 8519099Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: January 13, 2011Date of Patent: August 27, 2013Assignee: Life Technologies CorporationInventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Patent number: 8389681Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: December 29, 2006Date of Patent: March 5, 2013Assignee: Life Technologies CorporationInventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Patent number: 8012715Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: December 29, 2006Date of Patent: September 6, 2011Assignee: Life Technologies CorporationInventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20110108420Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: January 13, 2011Publication date: May 12, 2011Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: DEB K. CHATTERJEE, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20080268520Abstract: The present invention relates generally to compositions and methods for enhancing recombinational cloning of nucleic acid molecules. In particular, the invention relates to compositions comprising one or more ribosomal proteins and one or more additional protein components required for recombinational cloning. More particularly, the invention relates to such compositions wherein the ribosomal proteins are one or more E. coli ribosomal proteins, still more particularly wherein the ribosomal proteins are selected from the group of E. coli ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L20, L21, and L23 through L34, and most particularly S20, L27, and S15. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.Type: ApplicationFiled: October 6, 2006Publication date: October 30, 2008Applicant: INVITROGEN CORPORATIONInventors: Gary F. Gerard, Elizabeth Flynn, A-Li W. Hu
-
Patent number: 7265206Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: January 11, 2006Date of Patent: September 4, 2007Assignee: Invitrogen CorporationInventors: Deb K. Chatterjee, Mary C. Longo, Elizabeth Flynn, Robert W. Oberfelder
-
Patent number: 7259242Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: January 11, 2006Date of Patent: August 21, 2007Assignee: Invitrogen CorporationInventors: Deb K. Chatterjee, Mary C. Longo, Elizabeth Flynn, Robert W. Oberfelder
-
Publication number: 20070190606Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: December 29, 2006Publication date: August 16, 2007Applicant: INVITROGEN CORPORATIONInventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20070184527Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: December 29, 2006Publication date: August 9, 2007Applicant: INVITROGEN CORPORATIONInventors: Deb CHATTERJEE, Mary LONGO, Elizabeth FLYNN, Robert OBERFELDER
-
Patent number: 7223566Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: GrantFiled: December 8, 2003Date of Patent: May 29, 2007Assignee: Invitrogen CorporationInventors: Deb K Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20060286633Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: January 11, 2006Publication date: December 21, 2006Applicant: Invitrogen CorporationInventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20060269992Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: January 11, 2006Publication date: November 30, 2006Applicant: Invitrogen CorporationInventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Publication number: 20060074519Abstract: The medication administration accuracy of a number of hospitals is compared and reports are produced. Data is received from each of the reporting hospitals including dosage error information and matching characteristics on which the hospitals can be compared. The received data is merged to provide a medication accuracy comparison database, and comparison groups are established based on a predetermined characteristic of each hospital. An accuracy rate is calculated for each hospital, and a report is produced comparing the medication administration accuracy of each reporting hospital with other hospitals in the associated comparison group.Type: ApplicationFiled: August 19, 2005Publication date: April 6, 2006Inventors: Kenneth Barker, Elizabeth Flynn
-
Patent number: 6964861Abstract: The present invention relates generally to compositions and methods for enhancing recombinational cloning of nucleic acid molecules. In particular, the invention relates to compositions comprising one or more ribosomal proteins and one or more additional protein components required for recombinational cloning. More particularly, the invention relates to such compositions wherein the ribosomal proteins are one or more E. coli ribosomal proteins, still more particularly wherein the ribosomal proteins are selected from the group of E. coli ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L20, L21, and L23 through L34, and most particularly S20, L27, and S15. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.Type: GrantFiled: November 12, 1999Date of Patent: November 15, 2005Assignee: Invitrogen CorporationInventors: Gary F. Gerard, Elizabeth Flynn, A-Li W. Hu
-
Publication number: 20040204563Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.Type: ApplicationFiled: December 8, 2003Publication date: October 14, 2004Applicant: Invitrogen CorporationInventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
-
Patent number: D1026640Type: GrantFiled: June 2, 2021Date of Patent: May 14, 2024Assignee: Dyson Technology LimitedInventors: Andrew Drummond Flynn, Imogen Elizabeth Adams, Emily Mary Menzies, George Joseph Moone